Does suprascapular nerve block reduce shoulder pain following stroke: a double-blind randomised controlled trial with masked outcome assessment

<p>Abstract</p> <p>Background</p> <p>Shoulder pain is a common complication of a stroke which can impede participation in rehabilitation programs and has been associated with poorer outcomes. The evidence base for current medical and therapeutic management options of he...

Full description

Bibliographic Details
Main Authors: Crotty Maria, Shanahan E, Allen Zoe A
Format: Article
Language:English
Published: BMC 2010-09-01
Series:BMC Neurology
Online Access:http://www.biomedcentral.com/1471-2377/10/83
id doaj-ab93c065933f4f688f0e90dd50ca5b6f
record_format Article
spelling doaj-ab93c065933f4f688f0e90dd50ca5b6f2020-11-25T02:17:45ZengBMCBMC Neurology1471-23772010-09-011018310.1186/1471-2377-10-83Does suprascapular nerve block reduce shoulder pain following stroke: a double-blind randomised controlled trial with masked outcome assessmentCrotty MariaShanahan EAllen Zoe A<p>Abstract</p> <p>Background</p> <p>Shoulder pain is a common complication of a stroke which can impede participation in rehabilitation programs and has been associated with poorer outcomes. The evidence base for current medical and therapeutic management options of hemiplegic shoulder pain is limited. This study will evaluate the use of suprascapular nerve block injection as part of an interdisciplinary approach to the treatment of shoulder pain following stroke. The technique has previously been proven safe and effective in the treatment of shoulder pain associated with rheumatoid arthritis and degenerative shoulder conditions but its usefulness in a stroke population is unclear.</p> <p>Methods/Design</p> <p>A double blind randomised placebo controlled trial will assess the effect of a suprascapular nerve block compared with placebo in a population of 66 stroke patients. The trial will measure effect of injection on the primary outcome of pain, and secondary outcomes of function and quality of life. Measurements will take place at baseline, and 1, 4 and 12 weeks post intervention. Both groups will continue to receive routine physiotherapy and standard ward care.</p> <p>Discussion</p> <p>The results of this study could reduce pain symptoms in persons with mechanical shoulder pain post stroke and provide improvement in upper limb function.</p> <p>Trial Registration</p> <p>This trial is registered with the Australian New Zealand Clinical Trials Registry (ANZCTR) - ACTRN12609000621213.</p> http://www.biomedcentral.com/1471-2377/10/83
collection DOAJ
language English
format Article
sources DOAJ
author Crotty Maria
Shanahan E
Allen Zoe A
spellingShingle Crotty Maria
Shanahan E
Allen Zoe A
Does suprascapular nerve block reduce shoulder pain following stroke: a double-blind randomised controlled trial with masked outcome assessment
BMC Neurology
author_facet Crotty Maria
Shanahan E
Allen Zoe A
author_sort Crotty Maria
title Does suprascapular nerve block reduce shoulder pain following stroke: a double-blind randomised controlled trial with masked outcome assessment
title_short Does suprascapular nerve block reduce shoulder pain following stroke: a double-blind randomised controlled trial with masked outcome assessment
title_full Does suprascapular nerve block reduce shoulder pain following stroke: a double-blind randomised controlled trial with masked outcome assessment
title_fullStr Does suprascapular nerve block reduce shoulder pain following stroke: a double-blind randomised controlled trial with masked outcome assessment
title_full_unstemmed Does suprascapular nerve block reduce shoulder pain following stroke: a double-blind randomised controlled trial with masked outcome assessment
title_sort does suprascapular nerve block reduce shoulder pain following stroke: a double-blind randomised controlled trial with masked outcome assessment
publisher BMC
series BMC Neurology
issn 1471-2377
publishDate 2010-09-01
description <p>Abstract</p> <p>Background</p> <p>Shoulder pain is a common complication of a stroke which can impede participation in rehabilitation programs and has been associated with poorer outcomes. The evidence base for current medical and therapeutic management options of hemiplegic shoulder pain is limited. This study will evaluate the use of suprascapular nerve block injection as part of an interdisciplinary approach to the treatment of shoulder pain following stroke. The technique has previously been proven safe and effective in the treatment of shoulder pain associated with rheumatoid arthritis and degenerative shoulder conditions but its usefulness in a stroke population is unclear.</p> <p>Methods/Design</p> <p>A double blind randomised placebo controlled trial will assess the effect of a suprascapular nerve block compared with placebo in a population of 66 stroke patients. The trial will measure effect of injection on the primary outcome of pain, and secondary outcomes of function and quality of life. Measurements will take place at baseline, and 1, 4 and 12 weeks post intervention. Both groups will continue to receive routine physiotherapy and standard ward care.</p> <p>Discussion</p> <p>The results of this study could reduce pain symptoms in persons with mechanical shoulder pain post stroke and provide improvement in upper limb function.</p> <p>Trial Registration</p> <p>This trial is registered with the Australian New Zealand Clinical Trials Registry (ANZCTR) - ACTRN12609000621213.</p>
url http://www.biomedcentral.com/1471-2377/10/83
work_keys_str_mv AT crottymaria doessuprascapularnerveblockreduceshoulderpainfollowingstrokeadoubleblindrandomisedcontrolledtrialwithmaskedoutcomeassessment
AT shanahane doessuprascapularnerveblockreduceshoulderpainfollowingstrokeadoubleblindrandomisedcontrolledtrialwithmaskedoutcomeassessment
AT allenzoea doessuprascapularnerveblockreduceshoulderpainfollowingstrokeadoubleblindrandomisedcontrolledtrialwithmaskedoutcomeassessment
_version_ 1724885252698013696